
AI Optics is transforming point-of-care diagnostics with innovative handheld imaging technology and AI-based disease screening software. Their products, including the FDA-cleared Sentinel Camera and the investigational Sentinel Pro, aim to increase access to eye screening and empower healthcare professionals to make informed decisions quickly. By focusing on early diagnosis and user-friendly design, AI Optics is positioned to revolutionize medical diagnostics and improve patient outcomes in various healthcare settings.

AI Optics is transforming point-of-care diagnostics with innovative handheld imaging technology and AI-based disease screening software. Their products, including the FDA-cleared Sentinel Camera and the investigational Sentinel Pro, aim to increase access to eye screening and empower healthcare professionals to make informed decisions quickly. By focusing on early diagnosis and user-friendly design, AI Optics is positioned to revolutionize medical diagnostics and improve patient outcomes in various healthcare settings.
Headquarters: New York, NY (145 Lexington Ave)
Flagship product: Sentinel Camera (handheld retinal imaging, FDA 510(k) cleared)
Pipeline product: Sentinel Pro (handheld camera with investigational on-device AI screening)
Founded: 2020
Employee count: 16
Point-of-care retinal disease screening (diabetic retinopathy, AMD, glaucoma).
2020
Medical devices, Digital health
300000.00
Total funding reported as $300,000 (currency USD) with last funding date listed 2024-09-27 in provided snapshot.
“Luminate; NYU Langone Health holds equity”